Dendreon Corp (DNDN)

0.06
0.00 6.02
NASDAQ : Health Care
Prev Close 0.06
Open 0.06
Day Low/High 0.06 / 0.06
52 Wk Low/High 0.04 / 3.46
Volume 1.37M
Avg Volume 5.11M
Exchange NASDAQ
Shares Outstanding 158.72M
Market Cap 20.16M
EPS -1.95
P/E Ratio N/A
Div & Yield N.A. (N.A)
Stock Futures Rise On Positive US Jobs Report

Stock Futures Rise On Positive US Jobs Report

Stocks close mixed even after strong December jobs report; Europe worries weigh on the market

Cramer's 'Mad Money' Recap: Elixir of Job Growth (Final)

Cramer's 'Mad Money' Recap: Elixir of Job Growth (Final)

Cramer says job growth can counter the tough financial crisis in Europe.

'Mad Money Lightning Round': Dendreon Goes Higher

'Mad Money Lightning Round': Dendreon Goes Higher

Cramer says the stock will benefit from the short squeeze.

Thursday's Top 10 Articles, Videos

Thursday's Top 10 Articles, Videos

These stories made today's top 10 list of articles and videos on TheStreet.

Dendreon: Provenge Q4 Sales Beat

Dendreon: Provenge Q4 Sales Beat

Dendreon surprises with better-than-expected sales of its prostate cancer therapy Provenge in the December quarter.

Dendreon Announces Fourth Quarter Revenues And Update On Commercialization

Dendreon Announces Fourth Quarter Revenues And Update On Commercialization

Dendreon Corporation (Nasdaq: DNDN) today announced revenue for the fourth quarter ended December 31, 2011, reporting gross product revenue of approximately $82 million.

Biotech Buyside Predictions for 2012

Biotech Buyside Predictions for 2012

Gilead Sciences is loved, Amgen is hated and new drug launches will continue to struggle, say Wall Street's biotech investing pros.

Dendreon Announces Webcast Presentation At J.P. Morgan Healthcare Conference

Dendreon Announces Webcast Presentation At J.P. Morgan Healthcare Conference

Dendreon Corporation (NASDAQ:DNDN) today announced that management will present at the 29th Annual J.

Biotech 2012 Kickoff Party: Investor Preview

Biotech 2012 Kickoff Party: Investor Preview

What every biotech investor needs to know before next week's J.P. Morgan Healthcare Conference.

10 Biggest Stock Value Killers of 2011 (Update 1)

10 Biggest Stock Value Killers of 2011 (Update 1)

There were plenty of examples of management hubris and poor judgment among Wall Street's movers and shakers that destroyed stock value this year.

Who Destroyed the Most Shareholder Value in 2011?: Poll

Who Destroyed the Most Shareholder Value in 2011?: Poll

Some Wall Street movers and shakers manage to destroy stocks purely through hubris.

The Worst Biotech CEO of 2011 Is ...

The Worst Biotech CEO of 2011 Is ...

TheStreet's readers tagged this biotech chief executive with the 'worst' title, topping four other nominees.

Dendreon's CEO Discusses NASDAQ OMX 27th Investor Program - Earnings Call Transcript

Dendreon's CEO Discusses NASDAQ OMX 27th Investor Program - Earnings Call Transcript

Dendreon's CEO Discusses NASDAQ OMX 27th Investor Program - Earnings Call Transcript

Dendreon's CEO Presents At The NASDAQ OMX 27th Investor Program - Conference Call Transcript

Dendreon's CEO Presents At The NASDAQ OMX 27th Investor Program - Conference Call Transcript

Dendreon's CEO Presents at the NASDAQ OMX 27th Investor Program - Conference Call Transcript

Dendreon's CEO Presents At The NASDAQ OMX 27th Investor Program - Conference Call Transcript

Dendreon's CEO Presents At The NASDAQ OMX 27th Investor Program - Conference Call Transcript

Dendreon's CEO Presents at the NASDAQ OMX 27th Investor Program - Conference Call Transcript

Dendreon Agrees To Sell VICTRELIS™ (boceprevir) Royalty Interest For $125 Million

Dendreon Agrees To Sell VICTRELIS™ (boceprevir) Royalty Interest For $125 Million

Dendreon Corporation (NASDAQ:DNDN) today announced that it has agreed to sell for $125 million in cash its royalty interest related to intellectual property licensed to Schering-Plough Ltd.

Biotech Stock Mailbag: Affymax

Biotech Stock Mailbag: Affymax

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

5 Dumbest Thanksgiving Quiz Answers

5 Dumbest Thanksgiving Quiz Answers

There have been plenty of dumb things to be thankful for lately. Here are the answers to our holiday quiz, and congrats to the winner, Richard Greene.

Your Vote Counts: Who Is the Worst Biotech CEO of 2011?

Your Vote Counts: Who Is the Worst Biotech CEO of 2011?

The five nominees for Worst Biotech CEO of 2011 face the wrath of readers; one of whom will get tagged with this dishonorable award.

The Five Dumbest Things on Wall Street Thanksgiving Quiz

The Five Dumbest Things on Wall Street Thanksgiving Quiz

Test your knowledge of Wall Street's antics over the past few months.

Dendreon Announces Webcast Presentation At Upcoming Conferences

Dendreon Announces Webcast Presentation At Upcoming Conferences

Dendreon Corporation (Nasdaq:DNDN) today announced that management will present at the following conferences: Deutsche Bank BioFEST in Boston, Massachusetts on December 5, 2011 at 9:30 am ET ...

Dendreon Announces The Centers For Medicare And Medicaid Services (CMS) Will Now Cover Infusion Costs Associated With The Administration Of PROVENGE

Dendreon Announces The Centers For Medicare And Medicaid Services (CMS) Will Now Cover Infusion Costs Associated With The Administration Of PROVENGE

Dendreon Corporation (NASDAQ:DNDN) today announced the Centers for Medicare and Medicaid Services (CMS) updated their coverage policy to now cover the infusion costs associated with the administration of ...

Biotech Stock Live Chat

Biotech Stock Live Chat

TheStreet's biotech columnist Adam Feuerstein is holding a live, interactive discussion about biotech stock investing.

Stocks to Watch: Wal-Mart, Home Depot, Staples

Stocks to Watch: Wal-Mart, Home Depot, Staples

Wal-Mart's U.S. same-stores sales rise 1.3%, reversing declines. The stock is lower in premarket trading Tuesday.

10 Investments Billionaire Steven Cohen Is Making Now

10 Investments Billionaire Steven Cohen Is Making Now

SAC Capital purchased the SPDR Gold Trust ETF and industrial gas company Praxair in the third quarter.

SAC Dumps Huge Dendreon Stake

SAC Dumps Huge Dendreon Stake

Billionaire hedge fund manager Steven Cohen likely took a huge loss in Dendreon when the stock blew up in August.

Dendreon Corp (DNDN): Today's Featured Health Care Loser

Dendreon Corp (DNDN): Today's Featured Health Care Loser

Dendreon was a leading decliner within the health care sector, falling 6 cents (-0.8%) to $7.21 on average volume.

The Day Ahead: Lifting Into the Weekend

Optimism about the eurozone is giving U.S. futures a boost today.

Looking at Four Biotechs

Looking at Four Biotechs

Here is my take on some questions from readers.

Dendreon Announces Election Of Dennis M. Fenton To Board Of Directors

Dendreon Announces Election Of Dennis M. Fenton To Board Of Directors

Dendreon Corporation (Nasdaq: DNDN) today announced that Dennis M.